Eiger Biopharmaceuticals Inc
EIGR · Chemicals & Drugs · NASDAQ · in our data January 30, 2014 to April 10, 2024 (10.2 years)
The first trading day in our data for Eiger Biopharmaceuticals Inc is January 30, 2014 (its first day in our records, which may be later than its listing and is not its founding). At its peak, on March 19, 2015, the market valued it at $650 million. It ended in a collapse: the last trade was $1.73, -100.0% from its split-adjusted high. The delisting record says: delisted or deregistered.
Share prices are adjusted for splits and other share changes, so the high and the last price compare like for like; the peak market value is as it was on the day. The return covers the trading days in our data only: it does not include what holders received, or lost, after the last trade (a merger payout, a bankruptcy), and it does not reach back before 2014. How these numbers are made · Report a data issue.
Play today's Daily DropAlso gone in 2024: Chemicals & Drugs
- Mirati Therapeutics Inc peaked at $12.1 billion
- Immunogen Inc peaked at $8.7 billion
- Livent Corp peaked at $6.3 billion
- Alpine Immune Sciences Inc peaked at $4.3 billion
- Deciphera Phrmctal Inc peaked at $3.8 billion
- Cymabay Therapeutics Inc peaked at $3.7 billion
